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Coexpression of CD9 augments the ability of membrane-bound hepa- fication of EGF and the EGF receptor (EGFR), other
rin-binding epidermal growth factor-like growth factor (proHB-EGF) growth factors have subsequently been identified thatto preserve renal epithelial cell viability.
also signal through the EGFR, including transformingBackground. Transfection of renal epithelial cells (NRK 52E) with
membrane-associated heparin-binding epidermal growth factor-like growth factor-a, amphiregulin, betacellulin, and heparin-
growth factor (proHB-EGF) increased renal epithelial cell survival by binding EGF-like growth factor (HB-EGF). A commonpromoting cell–cell and cell–extracellular matrix interactions. ProHB-
structural feature of these peptides is single or multipleEGF has been shown to form a complex in the plasma membrane with
the tetraspanin CD9, an interaction that significantly increases the EGF-like repeats in the extracellular domain, consisting
effectiveness of proHB-EGF as a juxtacrine mitogenic agent.
of six cysteine residues that form three intramolecularMethods. We examined whether the coexpression of proHB-EGF
and CD9 would increase renal epithelial cell survival. CD9 was stably disulfide bonds [1]. In addition to their roles as mitogens,
transfected into NRK 52E cells, either alone (NRKCD9) or together recent evidence has suggested that the EGF-like growthwith proHB-EGF (NRKboth).
factors may serve as cytoprotective agents [2, 3]. Of inter-Results. Juxtacrine mitogenic activity of NRKCD9 was no different
than in cells transfected with vector alone (NRKvector), but was increased est, two groups have reported that in fetal kidney, EGF
by NRKboth; juxtacrine mitogenic activity by NRKboth was twofold administration decreases apoptotic cell death in thegreater than when proHB-EGF was transfected alone (NRKproHB-EGF).
nephrogenic zone of the developing kidney cortex andWhen grown in 10% fetal calf serum, growth rates were similar among
all transfectants. However, in 1% fetal calf serum, NRKproHB-EGF grew in the developing medullary papilla [4, 5].
50% faster than NRKvector or NRKCD9, and NRKboth grew 20% to
Members of the EGF-like family of growth factors50% faster than NRKproHB-EGF at one, two, and three days of culture.
NRKproHB-EGF attachment to plastic substratum at one, two, and three are synthesized as membrane-anchored precursors. The
hours was 250% greater than that of NRKvector, and NRKboth was 20% precursor for HB-EGF (proHB-EGF) is a 206-aminoto 30% greater than that of NRKproHB-EGF. Coating plates with either
acid transmembrane protein and undergoes processingpoly 2-hydroxyethyl methacrylate or the GRGDTP peptide prevented
normal cell–extracellular matrix attachment, and NRKvector or NRKCD9 to an 86-amino acid secreted protein (mature HB-EGF)
failed to attach or form cell–cell attachments. NRKproHB-EGF exhibited [6–8]. Recent studies have indicated that membrane-300% and NRKboth exhibited 600% greater cell viability under these
conditions. Expression of type I and type III collagen mRNA was associated proHB-EGF processing to mature secreted
enhanced similarly in NRKproHB-EGF and NRKboth, but the expression of HB-EGF is mediated by a protein kinase C–dependent
b1 integrin was up-regulated only in NRKboth.
process [9]. Our and other studies have indicated thatConclusions. Coexpression of proHB-EGF and CD9 may render
the renal epithelial cells more resistant to disruption of cell–cell and membrane-associated proHB-EGF is also capable of ac-
cell–matrix interactions and could accelerate the re-establishment of tivating EGFR in adjacent cells and stimulating the cellsthese attachments.
to proliferate, so-called juxtacrine stimulation [10, 11].
Recent studies have indicated that CD9, a member of
the tetraspanin family of integral membrane proteins,Epidermal growth factor (EGF) is an important medi-
colocalizes and associates in the plasma membrane withator of epithelial cell growth. Following the initial identi-
proHB-EGF, and this interaction significantly increases
the juxtacrine mitogenic activity of membrane-boundKey words: extracellular matrix, cell growth, NRK 52E cells, growth
factor, heparin binding. proHB-EGF, although it does not alter the actions of
soluble HB-EGF [10, 12]. CD9 is expressed in devel-Received for publication February 10, 1998
oping and mature kidney in a distribution similar to thatand in revised form July 15, 1998
Accepted for publication August 19, 1998 of HB-EGF. In previous studies, we determined that
HB-EGF expression increased in rat kidney after acute 1999 by the International Society of Nephrology
71
Takemura et al: CD9 and HB-EGF prevent epithelial cell apoptosis72
ischemic insult, and expression of membrane-associated dishes that had been coated with poly 2-hydroxyethyl
HB-EGF conferred increased resistance to cytotoxicity methacrylate (polyHEMA, 10 mg/ml solution in ethanol;
in cultured renal epithelial cells [11, 13, 14]. These studies Sigma) or were spread on 96-well plastic culture dishes
were designed to determine if coexpression of HB-EGF containing 1 mg/ml of the peptide GRGDTP (Peninsula,
and CD9 in cultured renal epithelial cells afforded Belmont, CA, USA).
greater protection than proHB-EGF alone. For determination of [3H] thymidine incorporation,
cells were cultured in 24-well plates until confluence and
incubated in FCS-free DMEM medium for 72 hours be-METHODS
fore addition of agonist. After 18 hours of incubation
cDNA and vectors with or without agonist, 1 mCi/ml [3H] thymidine was
Rat membrane-anchored HB-EGF cDNA ligated into added, and incubation was continued for an additional
a eukaryotic expression vector (pRc/CMV plasmid; In- four hours. Cells were washed twice with ice-cold phos-
vitrogen, San Diego, CA, USA) was prepared as pre- phate-buffered saline (PBS) and were incubated with
viously described [11]. Rat CD9 cDNA was produced 10% trichloroacetic acid for 30 minutes on ice. After
by reverse transcriptase–polymerase chain reaction am- rinsing with ethanol, acid-precipitable materials were
plification from normal rat kidney RNA of the rat CD9 dissolved in 0.25 m NaOH/0.1% sodium dodecyl sulfate
coding region, using the primers 59-GAGCATGCCGG (SDS) and were counted by scintillation spectrometry.
TCAAAGGAGGTAG-39 and 59-TCAGCACATTTC For the determination of cell attachment, cells were
TCGGCTCC-39 and amplifying for 30 cycles at 588C for spread at a density of 1 3 105 cells onto plastic culture
45 seconds, 958C for 30 seconds, and 728C for 60 seconds. dishes (10 cm in diameter) with an attached grid. At
The amplified cDNA was ligated into pPCR II (In- the indicated time points, the plates were washed with
vitrogen), and the Hind III-Not I fragment was digested Hank’s buffered salt solution, and the total cells attached
and ligated into pRc/CMV. Rat b1 integrin oligonucleo- in 20 individual squares (0.5 cm2) were counted. In pre-
tide probe was purchased from Biognostik (Gottingen, liminary experiments, attachment was compared in 10%
Germany). FCS, 1% FCS, and serum-free conditions and was not
found to influence the rate of attachment in the first fourTransfection
hours. Therefore, experiments were routinely performed
NRK 52E cells were transfected by lipofectin (Life in 10% FCS.
Technologies, Gaithersburg, MD, USA) and were se- To determine cell viability, 10 ml of an MTT (3-[4,5-di-
lected by continuous growth in G418 (Geneticin; 400 methyl-thiazole-2-yl]-2,5-diphenyl tetrazolium bromide)
mg/ml; Life Technologies). After seven passages, clones
solution [5 mg/ml in PBS (2)] was added to each well
were isolated and screened for CD9 by slot blot and
[15]. Cells were harvested by adding 0.04 n HCl in isopro-Northern blot analysis. For construction of cells simulta-
panol after four hours, and OD590 was measured by mi-neously expressing proHB-EGF and CD9, a clone of
croplate reader.NRK 52E cells stably transfected with proHB-EGF
(E15) [11] was transfected with CD9, grown for seven RNA isolation and Northern blot analysis
passages, and selected for CD9 and proHB-EGF expres-
Total RNA from cultured cells was isolated by thesion by slot blot and Northern blot analysis. As a control,
acid guanidinium thiocyanate-phenol-chloroform methodNRK 52E cells were also transfected with pRc/CMV
[16]. Aliquots of total RNA, each consisting of 10 to 15plasmid alone and grown and maintained in G418.
mg, were subjected to electrophoresis, transferred to S &
S Nytran nylon membranes (Schleicher & Schuell,Cell culture
Keene, NH, USA), and fixed to the membrane by ultravi-Vector transfected NRK 52E cells (NRKvector), CD9
olet light exposure. The membranes were prehybridizedtransfected cells (NRKCD9), membrane-anchored HB-
in a solution of 50% formamide, 5 3 SSC, 0.5% (wt/EGF transfected cells (NRKproHB-EGF; E15) [11], and
vol) SDS, 5 3 Denhardt’s solution, and 100 mg/ml salmonproHB-EGF plus CD9 transfected cells (NRKboth) were
sperm DNA at 428C. Following prehybridization, blotsgrown in Dulbecco’s modified Eagle’s medium (DMEM;
were hybridized with 0.5 to 1.0 3 103 cpm/ml of 32P-Sigma, St. Louis, MO, USA) containing 10% fetal calf
labeled cDNA overnight at 428C. After washing with 2serum (FCS; HyClone, Logan, UT, USA) supplemented
3 SSC for 15 minutes at room temperature twice andwith 100 units/ml ampicillin and 100 mg/ml streptomycin.
at 658C with 1 3 SSC/0.1% SDS for 15 minutes, andTransfected cells were routinely grown in G418. For
finally with 0.2% SSC/0.1% SDS for an additional 15 min-studies of interruption of cell–extracellular matrix (ECM)
utes, the membranes were exposed to Kodak X-Omatassociations, cells were grown to confluence in 10-cm
AR film at 2708C with an intensifying screen. The blotsplastic tissue culture dishes, trypsinized and replated at
a density of 1 3 104 cells/well into 96-well plastic culture were stripped and reprobed with a human GAPDH
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Fig. 1. Expression of CD9 and HB-EGF
mRNA in transfected NRK-52E cells trans-
fected with rat proHB-EGF cDNA. Cells
were transfected with CD91 proHB-EGF
cDNA (NRKboth) (lane A), proHB-EGF
(NRKproHB-EGF) (lane B), empty vector
(NRKvector) (lane C) or CD9 (NRKCD9) (lane
D) and stable transfectants were selected by
neomycin resistance. Total RNA was hybrid-
ized with rat CD9 or rat HB-EGF cDNA as
indicated. The housekeeping gene GAPDH
is indicated for comparison.
cDNA using the conditions of labeling, hybridization, Measurement of apoptosis
and wash as described earlier here. Cells were treated with H2O2 (0.5 mm) for 30 hours.
Adherent cells were removed with a rubber policeman
Juxtacrine growth factor activity measurements
and were centrifuged with the supernatant. The cell pel-
Cells were plated in DMEM containing 10% FCS (3 let was washed 33 with PBS and were fixed with 1%
ml/well) in 50-mm plastic dishes and were incubated for glutaraldehyde in PBS for 15 minutes. Cells were then
48 to 72 hours. After reaching confluence, the cells were stained with bisbenzamide H33258 fluorochrome trihy-
washed three times with DMEM plus 2 m NaCl to wash drochloride (Calbiochem, La Jolla, CA, USA) for 20
away the soluble HB-EGF bound to cell surface heparan minutes and were examined by light and immunofluo-
sulfate proteoglycan and fixed with 5% buffered forma- rescent microscopy.
lin for five minutes [9]. The formalin-fixed cells were Apoptotic cells were determined by evidence of char-
washed twice with DMEM, scraped from the plate, and acteristic nuclear condensation, nuclear fragmentation,
resuspended. They were then added to subconfluent and apoptotic bodies, as well as increased fluorescent
monolayers of A431 cells for 24 hours. [3H] thymidine intensity of nuclei of apoptotic cells [18]. The percentage
was added for an additional two hours, and thymidine of apoptotic cells was determined by counting 100 cells
incorporation was determined as mentioned earlier here. per sample. For determination of DNA laddering by
agarose gel electrophoresis, subconfluent cells were ren-
Immunofluorescence dered quiescent by incubation for two days in DMEM
Fluorescein labeled antirat b1 integrin antibody (CD29) supplemented with 0.4% FCS. Cells were exposed to 0.5
was obtained from Pharmigen (San Diego, CA, USA). mm H2O2 for the indicated times and were collected
Anti-HB-EGF antibodies were from Santa Cruz Bio- by scraping cells into media in which they had been
technology (Santa Cruz, CA, USA); monoclonal antirat incubated. Floating cells were also collected. To analyze
CD-9 antibodies (B2C11) were a gift of Paul Patterson, for the characteristic laddering pattern of DNA degrada-
California Institute of Technology, USA. Indirect immu- tion in apoptosis, cells were lysed by adding DNA ex-
nofluorescence was performed as described previously tracted buffer [50 mm Tris-HCl (pH 7.8), 10 mm ethylene-
[17]. In brief, cells were cultured with DMEM containing diaminetetraacetate (EDTA) • Na, and 0.5% wt/vol
10% FCS in six-well plastic dishes, and subconfluent cells sodium-N-lauroylsarcosinate]. After phenol-chloroform
were fixed with 1% glutaraldehyde in PBS for 30 minutes extraction and high-speed centrifugation, DNA was re-
at room temperature and were then reacted with the ap- covered in the aqueous phase and was precipitated with
propriate antibody. For anti-CD9 and anti-HB-EGF, sheep ethanol/sodium acetate. Equal amounts of DNA (20 mg)
antimouse IgG-fluorescein isothiocyanate (FITC) and were applied to each well of a 1% agarose gel in TAE
rabbit antigoat IgG-Texas red isothiocyanate (TRIC; Cap- buffer (40 mm Tris-acetate, 1 mm EDTA); after electro-
phoresis, it was visualized with ethidium bromide.pel), respectively, were employed as secondary antibodies.
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Fig. 2. Immunoreactive CD9 and HB-EGF
expression in transfected cells. Expression of
CD9 (A and C) and HB-EGF (B and D) were
determined in (NRKvector) (A and B) or
(NRKboth) (C and D).
Statistics
Results are presented as the means 6 sem. Statistical
comparisons utilized ANOVA and the Bonferroni modi-
fication of Student’s t-test, with P , 0.05 indicating sig-
nificance.
RESULTS
In previous studies, we determined that HB-EGF is
predominantly expressed in epithelial cells of the distal
nephron in rat kidney [11, 13, 14]. For these studies, we
utilized NRK 52E cells, an immortalized, nontrans-
formed rat renal epithelial cell line that possesses charac-
teristics of the distal nephron. We have previously de-
scribed NRK 52E cells stably transfected with proHB-
EGF [11]. In these studies, NRK 52E cells were also
transfected with CD9 or were cotransfected with both
proHB-EGF and CD9 and selected by continuous
growth in G418. After seven passages, individual clones
Fig. 3. Juxtacrine stimulation of DNA synthesis by cells expressingwere selected. Figure 1 is a representative Northern blot
proHB-EGF 6 CD9. [3H] thymidine incorporation was measured inanalysis. There was minimal expression of either HB- quiescent subconfluent A431 cells overlain for 24 h with no cells ( ),
formalin-fixed NRKvector (h), formalin-fixed NRKCD9 ( ), formalin-fixedEGF or CD9 mRNA in either nontransfected cells or cells
NRKproHB-EGF (j) or formalin fixed NRKboth ( ) (*P , 0.05; #P , 0.01).transfected with the expression vector alone (NRKvector).
Expression of proHB-EGF alone did not significantly
increase basal expression of CD9 mRNA, nor did expres-
sion of CD9 alone increase HB-EGF mRNA expression. EGF was comparable between NRKproHB-EGF and NRKboth
In NRKvector, no immunoreactive CD9 or HB-EGF (Fig. (not shown).
2) could be detected, whereas in cells transfected with We have previously shown that NRK 52E cells ex-
both CD9 and proHB-EGF (NRKboth), immunoreactive pressing proHB-EGF are capable of juxtacrine activation
of EGF receptors [11], and previous studies in trans-CD9, and HB-EGF were observed. Expression of HB-
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Fig. 4. Effect of CD9 expression on growth of
renal epithelial cells expressing proHB-EGF.
(A) Growth rate NRKvector (h), NRKCD9 (n),
NRKproHB-EGF (r) and NRKboth (d) were plated
at a density of 1 3 105 cells/well in DMEM
supplemented with either 10% FCS (left) or
1% FCS (right) (*P , 0.05; #P , 0.01). (B)
Cell attachment. Symbols are: NRKvector (h),
NRKCD9 (n), NRKproHB-EGF (r), and NRKboth
(d) were plated at a density of 1 3 10 5 cells/
35 mm plate and the percentage of adherent
cells was determined at the indicated times (3
hours, *P , 0.05 and #P , 0.01).
when the cells were grown in 1% FCS, expression of
proHB-EGF promoted a faster and more sustained rate
of growth than was observed in NRKvector, and the simul-
taneous expression of CD9 augmented the ability of
proHB-EGF to sustain growth under these conditions,
whereas transfection with CD9 alone had no significant
effect upon growth rate (Fig. 4A).
As previously described [11], when plated at high den-
sity, the initial attachment of NRKproHB-EGF to plastic sub-
stratum at one, two, and three hours was significantly
greater than observed for NRKvector. Expression of CD9
alone had no effect on the rate of transfection, but attach-
ment was greater in proHB-EGF–transfected cells that
coexpress CD9 than with proHB-EGF expression alone
(Fig. 4B). Similarly, coexpression of CD9 augmented the
ability of cells expressing proHB-EGF to survive in the
absence of FCS (not shown).
ProHB-EGF expression protected renal epithelial
Fig. 4. Continued. cells from H2O2-induced injury [11]. In these studies,
we found that coexpression of CD9 further augmented
cytoprotection. Thirty hours following H2O2 administra-
tion, 76% 6 5% of NRKvector demonstrated morphologicfected mouse L cells have demonstrated that coexpres-
sion with CD9 significantly augmented the proHB- evidence of apoptosis (nuclear condensation, nuclear
EGF’s juxtacrine activity [10]. In these studies, formalin fragmentation, and apoptotic bodies, as well as increased
fixed NRKvector did not stimulate [3H] thymidine incorpo- fluorescent intensity of nuclei of apoptotic cells) com-
ration in quiescent, subconfluent A431 cells (Fig. 3), nor pared with 40% 6 12% of NRKproHB-EGF, and 28% 6 8%
was there stimulation by formalin-fixed NRK 52E cells of NRKboth (NRKvector vs. NRKproHB-EGF, P , 0.05; NRKvector
expressing CD9 alone. In contrast, formalin-fixed NRK vs. NRKboth, P , 0.01; NRKboth vs. NRKproHB-EGF, P , 0.1;
52E cells expressing proHB-EGF alone led to doubling N 5 4) (Fig. 5A) In addition, DNA fragmentation was
of [3H] thymidine incorporation, whereas cells expressing
determined at various times after administration of 0.5both proHB-EGF and CD9 demonstrated an approxi-
mm H2O2 to quiescent cells (Fig. 5B). In NRKvector, in-mate fourfold increase, confirming that in NRK 52E cells,
creased DNA fragmentation was observed at 20 hourscoexpression CD9 will increase the ability of proHB-
after H2O2 administration, and this pattern was unalteredEGF to activate EGF receptors in a juxtacrine manner.
in NRKCD9. As we have previously described [11], H2O2-When cells were plated at a density of 1 3 105 cells
induced DNA fragmentation was significantly decreasedin DMEM supplemented with 10% FCS, there were no
in NRKproHB-EGF at 20 and 30 hours compared withobvious differences in growth rate among NRKvector,
NRKCD9, NRKproHB-EGF and NRKboth (Fig. 4A). However, NRKvector, but by 40 hours, significant DNA degradation
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Fig. 5. Effect of CD9 1 proHB-EGF to prevent H2O2-induced apoptosis in renal epithelial cells. (A) Cells were treated with 0.5 mM H2O2 for
30 hours and stained with bisbenzamide H33258 as described in the Methods section. Representative fields of NRKvector (left) indicate characteristic
morphologic alterations and apoptotic bodies compared to relative structural preservation in the majority of NRKboth (right). (B) DNA laddering
in response to hydrogen peroxide. Subconfluent cells were made quiescent by incubation for two days in DMEM supplemented with 0.4% FCS
and were then exposed to 0.5 mM H2O2 for the indicated times. Both the cell monolayer and floating cells were collected and analyzed.
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Fig. 6. Effect of CD9 1 proHB-EGF expres-
sion on renal epithelial cells under conditions
of disrupted cell–extracellular matrix (ECM)
interactions. (A) Cells were cultured on poly-
HEMA coated dishes, which prevents cell at-
tachment to substratum. At 24 hours, both
NRKvector and NRKboth remained rounded.
However, unlike NRKvector, NRKboth were
found to form cell clusters (arrows). (B)
NRKvector (h), NRKCD9 ( ), NRKproHB-EGF (j),
and NRKboth ( ) were cultured on poly-
HEMA coated dishes or in the presence of
GRGDTP peptide and cell viability was mea-
sured after 24 hours by MTT incorporation
(*P , 0.05; #P , 0.01).
could be observed, whereas in NRKboth, no DNA lad- To further examine the ability of CD9 to augment
the ability of proHB-EGF to promote cell–ECM anddering was detectable at 40 hours.
When wild-type or vector-transfected NRK 52E cells cell–cell attachment and to promote epithelial cell sur-
vival, we examined whether coexpression of CD9 alteredwere plated onto dishes coated with polyHEMA, the
cells remained rounded (Fig. 6A) and underwent pro- production of components of the ECM. As we have
previously described [11], expression of type I and typegrammed cell death, as indicated by decreased MTT
uptake (Fig. 4B), as well as detection of apoptotic bodies, III collagen mRNA was enhanced in NRKproHB-EGF, com-
pared with NRKvector (Fig. 7A). NRK 52E cells expressDNA laddering, and decreased cell counts [11]. These
cells also failed to survive on plates coated with predominantly types I and III collagen, with minimal
type IV collagen expression [19]. The levels of types IGRGDTP, which blocks type I collagen, fibronectin, and
vitronectin integrin receptors. When plated onto poly- and III collagen expression in cells transfected with CD9
alone were not different than in cells transfected withHEMA, NRKboth formed cell clusters, although they
could not attach to the substratum (Fig. 6A), similar to vector alone. There was no consistent augmentation of
collagen gene expression in cells coexpressing CD9 andwhat we previously described in cells transfected with
proHB-EGF alone [11]. MTT assays revealed that trans- proHB-EGF, compared with expression of proHB-EGF
alone, although in some experiments, type III collagenfection with CD9 alone did not significantly alter cell
viability, whereas coexpression with CD9 augmented the mRNA levels were modestly increased over that seen
with proHB-EGF expression alone (Fig. 7A). Becauseability of proHB-EGF to promote survival when plated
onto either polyHEMA or GRGDTP (Fig. 6B). CD9 has been shown to interact with b1 integrins, we
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DISCUSSION
Our previous studies indicated that in the cultured rat
renal epithelial cell line NRK 52E, stable expression of
proHB-EGF stimulated cell growth rates and conferred
cytoprotection against hydrogen peroxide. In addition,
proHB-EGF expression increased collagen production
and promoted cell–cell contact [11]. In these studies, we
determined that coexpression of CD9 with proHB-EGF
significantly increased juxtacrine mitogenic actions com-
pared with proHB-EGF alone. In addition, these studies
indicated that coexpression of CD9 and HB-EGF in-
creased the ability of the cells to attach to substrata and
to survive in the absence of exogenous growth factors
or cell–ECM contact. Although there was no increase
in collagen production in cells transfected with proHB-
EGF/CD9 compared with proHB-EGF alone, coexpres-
sion of proHB-EGF and CD9 led to significant increases
in b1 integrin expression.
The mammalian kidney is susceptible to injury by is-
chemia/reperfusion and toxins [20]. Following ischemia/
reperfusion or toxin injury, tubule cells can undergo ne-
crosis or apoptosis [21–23]. Cell–cell and cell–matrix in-
teractions are also altered following acute renal injury
[24, 25]. Acute sublethal tubular injury disrupts cell po-
larity [26] and alters integrin receptor distribution in
epithelial cells [27].
The mechanisms by which the kidney epithelia are
repaired after acute injury are not completely under-
stood, but previous studies have suggested that EGF, or
members of the EGF growth factor family, may play an
important role in epithelial regeneration. After either
ischemic injury or folic acid nephropathy, 125I-EGF bind-
ing increases [28, 29], and subcutaneous injection of EGF
significantly accelerates [3H] thymidine incorporation
and recovery of tubular function.
Heparin-binding EGF is a 22 kDa glycoprotein that
Fig. 7. (A) Expression of type I and type III collagen mRNA. Aliquots was originally purified from conditioned media of U-
of total RNA (15 mg) from NRKboth (lane A), NRKproHB-EGF (lane B),
937 cells, a macrophage-like cell line [6]. In addition toNRKvector (lane C) or NRKCD9 (lane D) were subjected to Northern
analysis as described in the Methods section. Blots were stripped and macrophages, HB-EGF mRNA is expressed in other
reprobed with cDNA for the housekeeping gene, GAPDH. (B) Expres- hematopoietic cells, endothelial cells, vascular smooth
sion of b1 integrin mRNA. Aliquots of total RNA (15 mg) from NRKboth
muscle cells, keratinocytes, and intestinal and renal epi-(lane A), NRKproHB-EGF (lane B), NRKvector (lane C) or NRKCD9 (lane D)
were subjected to northern analysis with b1 integrin cDNA. thelial cells [13, 30, 31]. HB-EGF is a potent mitogen
for smooth muscle cells, fibroblasts, and epithelial cells
[13, 31] and is a motility factor for smooth muscle cells
[32]. HB-EGF mRNA and bioactive HB-EGF levels in-examined whether there were alterations of b1 integrin
crease in wound fluid [33]. Unlike expression of EGF,expression in NRK 52E cells expressing proHB-EGF
which decreases following acute renal injury [28], expres-and CD9. Transfection with CD9 did not alter expression
sion of renal HB-EGF mRNA and bioactive proteinof b1 integrin mRNA (Fig. 7B) and immunoreactive pro-
increases significantly in response to acute injury to thetein (Fig. 8), compared with NRKvector, and there was also
kidney [13, 14].minimally increased expression in cells transfected with
ProHB-EGF serves as the human “diphtheria toxinproHB-EGF alone. In cells coexpressing CD9 and
receptor,” with diphtheria toxin entering cells via bindingproHB-EGF, b1 integrin mRNA and immunoreactive
to, and endocytosis with, proHB-EGF [34]. Previousprotein were markedly increased compared with the
other transfectants. studies of the diphtheria toxin receptor (HB-EGF pre-
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Fig. 8. Expression of immunoreactive b1 in-
tegrin. Immunofluorescent detection of b1 in-
tegrin with a rat anti b1 integrin antibody
(CD29) was performed as described in the “Ex-
perimental Methods” section. NRKvector (A),
NRKCD9 (B), NRKproHB-EGF (C), NRKboth (D).
cursor) had determined that it forms a complex with a rat metanephric development, and in normal adult rat
kidney, immunoreactive HB-EGF expression was pre-27 kDa membrane protein, first designated DRAP27
(diphtheria receptor-associated protein). DRAP27 was dominantly confined to collecting duct and endothelial
cells [14]. For these studies, we utilized NRK 52E cells,subsequently found to be identical to CD9, which had
been first identified as a cell surface antigen on platelets an immortal, nontransformed rat renal epithelial cell
line that expresses EGF receptors and has characteristicsand other lymphohemopoietic cells [35]. CD9 belongs to
the tetraspanin membrane protein superfamily (TMP). consistent with a distal nephron origin [13, 42, 43]. NRK
52E cells do not express detectable endogenous CD9TMPs share common structural features as integral mem-
brane proteins composed of four transmembrane regions and also express minimal endogenous HB-EGF mRNA
at baseline, although expression does increase in re-with cytoplasmic amino- and carboxy-termini and with
several conserved cysteine-containing motifs and N-gly- sponse to mitogens, H2O2, and hypoxia/reoxygenation
(M. Sakai and R.C. Harris, unpublished observations).cosylation sites. TMPs have been implicated in control of
proliferation and differentiation, cell–cell and cell–ECM In Vero cells expressing HB-EGF and CD9, HB-EGF-
CD9 complexes were localized to the lateral membraneinteractions and signal transduction. TMPs appear to
serve as accessory molecules that stabilize and/or facili- in association with a-catenin and vinculin [44], and CD9
interacted specifically with a3b1 integrins at these adher-tate interactions of other proteins [36].
In addition to platelets and lymphopoietic cells, CD9 ence junctions. In polarized epithelial cells, EGF recep-
tors are also localized to sites of cell–cell contact in asso-is also expressed in mesenchymal and epithelial cells,
including cells of the kidney, nervous system, and intes- ciation with E-cadherin and a-catenin [45]. It is also
of interest that in NRK 52E cells, CD9 coexpressiontine [37, 38]. During murine fetal kidney development,
CD9 is expressed in the ureteric bud and late S-shaped increased b1 integrin expression, as b1 integrins appear
to be important for epithelial cell–cell interactions [46],body and is expressed predominantly along the basolat-
eral surface of distal tubular epithelial cells in mature and in cultured renal epithelial cells, a2b1, and a3b1 inte-
grins are localized to sites of cell–cell contact [47, 48]. Inmurine kidneys, with less intense expression on mesan-
gial cells and renal microvascular endothelial and smooth other studies, CD9 expression has been found to inhibit
motility of both normal and tumor cells [49–52]. There-muscle cells [38, 39]. A similar pattern has been described
in human kidney [40]. Of interest, hypertonicity appears fore, these results suggest that in the normal kidney local
juxtacrine interactions between HB-EGF and EGF re-to increase CD9 expression in distal renal tubular cells
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